Which hedge funds own CDNA? CAREDX INC, Q2 2026 13F holders
37 tracked hedge funds disclosed a position in CDNA (CAREDX INC) in their Q2 2026 13F filings, worth $351.2m in total. The largest holder by portfolio weight is Blue Water Life Science Advisors, LP at 21.4% of its book. 16 opened a new position this quarter: Divisadero Street Capital Management, LP, Fox Run Management, L.L.C., ExodusPoint Capital Management, LP, Gsa Capital Partners LLP. 2 exited: Brevan Howard Capital Management LP, Freestone Grove Partners LP.
- 37
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 16
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 2
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $56.0m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $382k
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $351m
- Combined value Sum of the holders' reported positions in the security.
- 3.0%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Brevan Howard Capital Management LP | 0.0% | $306k |
| Freestone Grove Partners LP | 0.0% | $76.7k |
Ownership over time
Who discovered CDNA first? Beta
The run: Q2 2017 → Q2 2019, ×32
| Gagnon Advisors, LLC high conviction | Q3 2017 | 0.9% | +31.2 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.